NUCLEIX
Dead / Abandoned — Abandoned — failure to respond (as of 20 Apr 2024)
What this means for you
This application is over — abandoned 05 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97842013
- Mark type
- Design + words
- Filed
- 16 Mar 2023
- Abandoned
- 05 Apr 2024
- Attorney of record
- Jennifer Sheehan Anderson
Goods and services
- Class 001 — Chemicals: Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection or detection of or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; diagnostic reagents for medical purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays
- Class 044 — Medical, beauty and agricultural services: Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease and prognosis of expected progression of the diseases; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing cancer screening services; providing screening services for chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease; providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Owner
- Nucleix Limited, Rehovot, IL
Prior registrations
Prosecution history
- 20 Apr 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 20 Apr 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 04 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Jan 2024 — NON-FINAL ACTION E-MAILED
- 04 Jan 2024 — NON-FINAL ACTION WRITTEN
- 13 Dec 2023 — ASSIGNED TO EXAMINER
- 07 Apr 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 06 Apr 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Mar 2023 — NEW APPLICATION ENTERED